Strategic knowledge resource provides our Equity Research and Investment Banking teams and clients with exclusive insights pertaining to the evolution of healthcareContact Us
Access to Key Opinion Leaders (KOLs) and healthcare-focused professionals within the MEDACorp network, helps to identify and deliver actionable recommendations to our clients. The MEDACorp network provides real-time insight pertaining to clinical development, regulatory headwinds (and tailwinds) and other commercialization dynamics providing invaluable guidance in the assessment of business and investment decisions.
Our network of over 20,000 academic physicians, office-based physicians, clinicians, regulatory and reimbursement specialists, attorneys, hospital administrators and more, have long served as the foundation of our differentiated research and guidance. Their expertise spans Pharma, Biopharma, Medtech, Diagnostics, Healthcare Services and IT with coverage of ~50 clinical specialties and 21 basic science disciplines.
We invite healthcare professionals to learn more about our network and the impact to be made on emerging companies and their innovations.
Contact us to learn more about our MEDACorp Network.
MEDACorp’s rigorous compliance procedures and protocol are shaped by securities laws and regulations, and industry best practices. They are supported by our experienced internal compliance team and by our proprietary technology.
Terms and Conditions
1. To educate and assist MEDACorp consultants and clients regarding material, non-public information, we have prepared a list of FAQs.
2. MEDACorp’s proprietary technology tracks all MEDACorp interactions to ensure the adherence to compliance protocols.
MEDACorp LLC (“MEDACorp”) is a wholly-owned subsidiary of Leerink Partners LLC.
Managing Director, Head of MEDACorp
Robert Parente is a Managing Director at Leerink Partners and the Head of MEDACorp. For over 20 years, MEDACorp’s global network of healthcare professionals has served as a foundation of Leerink Partners’s differentiated guidance and assistance for its clients.
Mr. Parente joined Leerink Partners in 1995 as its first Equity Analyst. He was an analyst for approximately 10 years, covering Biotech, Pharma, Medtech and Diagnostic companies and then transitioned to the Investment Banking team where he was Head of Venture Capital Services. In this role, Mr. Parente introduced the VC community to Leerink Partners’s MEDACorp and Investment Banking services. In 2011, he became the Head of MEDACorp, the firm’s network of over 20,000 healthcare professionals, that expedite and differentiate its Equity Research and Investment Banking offerings. Prior to joining the firm, Mr. Parente worked for both Merrill Lynch and United Parcel Service.
He earned his undergraduate degree in Economics from Yale University.